Taken together our study demonstrates that whereas ANGPTL4 promotes the malignancy phenotype of cutaneous melanoma cells in early stages of brain metastasis, it ameliorates the malignancy phenotype of MBM cells in the later stages of brain metastasis, when the brain tumor microenvironment plays a significant functional role in disease progression. Here, ANGPTL4 is linked to brain neoplasm.